FDA Warning Letter
Carive Imports Inc.
Foreign Supplier Verification Program (FSVP)
- 発出日
- 2026.10.13
- 掲載日
- 2026.11.10
- 発行オフィス
- Division Of Northeast Import
- Reference #
- CMS# 730156
- MARCS-CMS 番号
- 730156
- 配達方法
- Via Email
- 宛先
- Samuel Garcia
本文(英語原文)
- Delivery Method:
- Via Email
- Reference #:
- CMS# 730156
- Product:
- Food & Beverages
- Recipient:
-
Recipient NameSamuel Garcia
-
Recipient TitleOwner
- Carive Imports Inc.
1251 Randall Ave
Bronx, NY 10474-6411
United States- (b)(6), (b)(7)(C)
- Issuing Office:
- Division Of Northeast Import
United States
United States
WARNING LETTER
Dear Mr. Samuel Garcia:
On March 30, 2026 through April 22, 2026, the Food and Drug Administration (FDA) conducted a Foreign Supplier Verification Program (FSVP) inspection of Carive Imports Inc., located at 1251 Randall Ave, Bronx, NY 10474-6411. We also conducted inspections on August 24, 2017, September 27, 2018, March 10, 2020, and June 21, 2022 through July 8, 2022. These inspections were conducted to determine compliance with the requirements of section 805 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C.384a) and the implementing FSVP regulation in 21 CFR part 1, subpart L.
The FSVP regulation requires that importers perform certain risk-based activities to verify that human and/or animal food they import into the United States has been produced in a manner that meets applicable U.S. food safety standards. You may find information relating to the FSVP regulation and your responsibilities to comply with the regulation through links in FDA’s FSVP web page at https://www.fda.gov/food/food-safetymodernization-act-fsma/fsma-final-rule-foreign-supplier-verification-programs-fsvp-importers-foodhumans-and-animals.
During the most recent inspection, we found that you are not in compliance with the requirements of 21 CFR part 1, subpart L for the foods you import. Because of these significant violations, you are not in compliance with section 805 of the FD&C Act. At the conclusion of the inspection, our investigator provided you with a Form FDA 483a FSVP Observations. We have not received your response to the Form FDA 483a issued on April 22, 2026.
Your significant violations of the FSVP regulation are as follows:
If requested in writing by FDA, you must send records to the Agency electronically or through another means that delivers the records promptly, rather than making the records available for review at your place of business, as required by 21 CFR 1.510(b)(3). On March 30, 2026, our Investigator provided you with a Form FDA 482d Request for FSVP Records and spoke with you by telephone. In that conversation, you stated you would send your FSVP records. Additionally, our Investigator contacted you multiple times by email between April 2 and April 21, 2026. However, you failed to send records electronically or through another means after receiving our request in writing. As of the date of this letter, we have not received any records from you including FSVP documents for any of the foods you import, including:
- garlic paste imported from (b)(4) located in (b)(4)
- cookies imported from (b)(4) located in (b)(4)
- noodles imported from (b)(4) located in (b)(4)
- pigeon peas imported from (b)(4) located in (b)(4)
The above violations are not intended to be an all-inclusive list of violations of the FSVP requirements. It is your responsibility to ensure that you are in compliance with section 805 of the FD&C Act and the implementing regulation in 21 CFR part 1, subpart L.
This letter notifies you of our concerns and provides you with an opportunity to address them. If you do not adequately address this matter, we may take further action. For instance, we may take action under section 801(a)(3) of the FD&C Act (21 U.S.C. 381(a)(3)) to refuse admission of the food you import for which you appear to be in violation of section 805. We may place the foods you import into the United States on detention without physical examination (DWPE) when you import the foods. You can find DWPE information relating to FSVP in Import Alert # 99-41 at http://www.accessdata.fda.gov/cms_ia/ialist.html. In addition, the importation or offering for importation into the United States of an article of food without the importer having an FSVP that meets the requirements of section 805 of the FD&C Act or the FSVP regulation is prohibited under section 301(zz) of the FD&C Act (21 U.S.C. 331(zz)).
You should respond in writing within fifteen (15) working days from your receipt of this letter. Your response should address the specific things you are doing to correct any violations. You should include in your response documentation and information that would assist us in evaluating your corrections (e.g., documentation of changes you made, such as a copy of your FSVP, records to demonstrate implementation of your FSVP), and any additional information that you wish to supply relevant to your compliance with the FSVP regulation. If you believe that you are not in violation of the FD&C Act, include your reasoning and any supporting information for our consideration. If you cannot complete all corrections within 15 working days, you should explain the reason for your delay and state when you will correct any remaining violations.
Please send your reply to Food and Drug Administration, Attention: Jananiga Vanniyasingam, Compliance Officer, Division of Northeast Imports: oiioiodneiwlresponses@fda.hhs.gov. Please also cc (carbon copy) Jananiga.vanniyasingam@fda.hhs.gov. If you have any questions regarding this letter, you may contact Compliance Officer Vanniyasingam via email at ananiga.vanniyasingam@fda.hhs.gov. Please reference CMS # 730156 on any documents or records you provide to us and on the subject line of any email correspondence you send to us.
Sincerely,
/S/
CDR Joseph S. Tomao
Program Division Director
Division of Northeast Imports
出典: fda.gov(U.S. FDA)の Warning Letters 公開情報 (米国政府著作物としてパブリックドメイン)をそのまま掲載しています。内容の正確性・最新性は保証されません。FDA が本サイトの内容を承認・保証するものではありません。
Warning Letter の最新状態・Close-out(是正完了)の正は FDA 公式サイトです。是正が完了した企業には Close-out Letter が発行される場合があり、本サイトの表示が最新の状態を反映していないことがあります。掲載は事実の転載であり、企業の現在の法令遵守状況について評価・断定するものではありません。
取得日: 2026.11.17
各データセット(510(k)・PMA・MAUDE・回収・Warning Letter)の解説は 米国FDA情報の概要 を参照してください。